Maternal toxicity--a possible factor in fetal malformations in mice
- PMID: 6379969
- DOI: 10.1002/tera.1420290312
Maternal toxicity--a possible factor in fetal malformations in mice
Abstract
The assumption that major fetal malformations are indicative of a chemical's teratogenic potential was not supported by a literature review of teratology studies conducted in mice. In these studies, dose levels of test agents that manifested maternal toxicity as suggested by reduction in dam's body weight, clinical signs of toxicity, or deaths, also invariably caused reduction in fetal body weight, increased resorptions, and rarely fetal deaths. In several such studies, conducted with maternotoxic doses of structurally unrelated test agents, a consistent pattern of fetal defects was discovered. These defects included exencephaly, open eyes, hemivertebrae, fused arches or centra of lumbar or thoracic vertebrae, fused, missing or supernumerary ribs, and fused or scrambled sternebrae. These defects were absent at drug dosages that were distinctly nontoxic for the mother. In a few studies conducted at two or more maternally toxic doses, the degree and severity of maternal toxicity showed a positive correlation with the incidence and severity of above fetal defects. It is hypothesized that maternal toxicity, on its own, may have an etiologic role in these fetal defects.
Similar articles
-
Maternal toxicity: a possible etiological factor in embryo-fetal deaths and fetal malformations of rodent-rabbit species.Teratology. 1985 Feb;31(1):129-53. doi: 10.1002/tera.1420310115. Teratology. 1985. PMID: 3983854
-
Different embryo-fetal toxicity effects for three VLA-4 antagonists.Birth Defects Res B Dev Reprod Toxicol. 2004 Apr;71(2):55-68. doi: 10.1002/bdrb.20001. Birth Defects Res B Dev Reprod Toxicol. 2004. PMID: 15098199
-
The role of maternal toxicity in lovastatin-induced developmental toxicity.Birth Defects Res B Dev Reprod Toxicol. 2004 Jun;71(3):111-23. doi: 10.1002/bdrb.20005. Birth Defects Res B Dev Reprod Toxicol. 2004. PMID: 15282732
-
Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits.Birth Defects Res B Dev Reprod Toxicol. 2003 Feb;68(1):5-26. doi: 10.1002/bdrb.10005. Birth Defects Res B Dev Reprod Toxicol. 2003. PMID: 12852480 Review.
-
Maternal toxicity of drugs and metabolic disorders--a possible etiologic factor in the intrauterine death and congenital malformation: a critique on human data.Crit Rev Toxicol. 1987;17(4):345-75. doi: 10.3109/10408448709029326. Crit Rev Toxicol. 1987. PMID: 3308323 Review.
Cited by
-
Developmental toxicity evaluation of orthovanadate in the mouse.Biol Trace Elem Res. 1991 Sep;30(3):219-26. doi: 10.1007/BF02991416. Biol Trace Elem Res. 1991. PMID: 1720642
-
Phase specificity of developmental toxicity after oral administration of mono-n-butyl phthalate in rats.Arch Environ Contam Toxicol. 1996 Aug;31(2):170-6. doi: 10.1007/BF00212362. Arch Environ Contam Toxicol. 1996. PMID: 8781065
-
Developmental toxicity evaluation of gallium nitrate in mice.Arch Toxicol. 1992;66(3):188-92. doi: 10.1007/BF01974013. Arch Toxicol. 1992. PMID: 1497482
-
Effects of alpha-lipoic acid supplementation on maternal diabetes-induced growth retardation and congenital anomalies in rat fetuses.Mol Cell Biochem. 2004 Jun;261(1-2):123-35. doi: 10.1023/b:mcbi.0000028747.92084.42. Mol Cell Biochem. 2004. PMID: 15362495
-
Embryotoxicity and teratogenicity of uranium in mice following subcutaneous administration of uranyl acetate.Biol Trace Elem Res. 1993 Feb;36(2):109-18. doi: 10.1007/BF02783169. Biol Trace Elem Res. 1993. PMID: 7681302
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical